YouTube - Joe Rogan chats with biohacker and human biologist Gary Brecka. (Watch podcast)

Forbes - Tony Robbins’ retreat “The Estate”, hires first Chief Longevity Officer. (Read more)

Reuters - Eli Lilly has another knockout drug on its hands, potentially helping millions of Americans with inherited heart disease . (Read more)

Vogue - DNA-coded skincare & wearable nanobots; the future of beauty lies within regenerative science. (Read more)

Investopedia - Your financial health matters. Here’s how to build savings that match your lifespan. (Read more)

GlobeNewswire - Longevity Health Holdings merges with 20/20 Biolabs. (Read more)

Fox News Chicago - Chicago suburban woman hits 107. Here are her secrets. (Read more)

RFK claims “autism epidemic” to be revealed by September. (Read more)

RFK is on board with the measles vaccine. (Read more)

RFK’s chronic disease push clashes with regulators. (Read More)

STORY OF THE WEEK

THE “BLUE ZONE” CRUISE THAT GOES ON FOREVER

The MV Narrative is not your typical cruise. It’s not even really a cruise. It's a lifestyle vessel, a perma-vacation for the well-heeled and restless.

Think of it as a floating condo complex with Wi-Fi, spa treatments, and a shared fantasy: to become the first “blue zone” at sea.

The ship will sail continuously around the world, with restaurants curated by longevity experts and a medical staff ready to fine-tune your microbiome.

A chance at immortality—with a view! Not too shabby. 😏

In their bid to outlive us all, Narrative residents may find the true secret to longevity isn’t plant-based diets or stress reduction—it’s never having to fold laundry or park a car again.

If forever looks like an all-you-can-eat buffet with a view of Bora Bora, sign us up.

👉🏾 Take a deeper dive into MV Narrative and the vision behind the ship.

PRODUCT REVIEW

BLUEPRINT: LONGEVITY MIX

It’s been 3 months since I started taking Bryan Johnson’s “Longevity Mix”, a critical component of his Blueprint stack.

The quick answer: it’s working well.

Time for a a review.

A primer on what this supplement blend consists of:

The Longevity Mix is Blueprint’s attempt to simplify the extreme supplement stack Bryan Johnson takes as part of his protocol. Instead of swallowing 20+ pills a day, this product delivers many of the same ingredients in one blood-orange-flavored scoop.

The powdered mix is designed to support sleep, stress reduction, cellular energy, muscle recovery, and overall health span.

It’s vegan, keto-friendly, and sweetened with monk fruit.

Each pouch is $46 for a 30-day supply—which may be a slight premium if you created it yourself, but it takes out the guesswork in precision measuring.

​🧬 What’s Actually Inside?

Here’s the ingredient breakdown and why the Blueprint team have included it:

• Creatine Monohydrate – Muscle performance, brain energy

• KSM-66 Ashwagandha – Adaptogen for stress and cortisol regulation

• Glycine – Sleep and cellular repair

• L-Theanine – Calm focus and reduced anxiety

• Ca-AKG (Calcium Alpha-Ketoglutarate) – Mitochondrial function and longevity potential

• L-Glutathione (Reduced) – Master antioxidant

• Taurine – Heart and brain support

• L-Lysine – Collagen formation and immune health

• Vitamin C – Antioxidant and immune booster

• Magnesium Citrate – Nervous system regulation

• Sodium Hyaluronate & Glucosamine Sulfate – Joint and skin support

Onto the review, and let’s start with the positives:

• Convenience is king. For anyone who's juggling multiple pill bottles and supplement, having it all in one scoop is genuinely helpful. I found this to be really simple and easy to incorporate into my morning routine, in the latter part of my morning when I would normally re-fill the coffee cup.

• Solid ingredient choices. Most of what’s in the mix has clinical backing for performance, recovery, and long-term cellular health.

And most importantly - how do I feel?

The biggest difference was in energy and focus.

I have eliminated a cup of coffee from my day and substituted it with the Longevity Mix.

It is mild though, so if you are looking for a “double-espresso”-type boost, this isn’t it.

⚠️ Any red flags?

• Right in the gut - Some mornings, particularly on an empty stomach, I noticed some rumblings right in my gut. Not a bloating feeling. Just an unsettling feeling. If you are new to any of the ingredients in the mix, begin with a ½ dose and pair it with a small meal.

• Flavor. It’s not great. Is it supposed to taste great? Probably not, but buyer beware you might not love the taste.

• Nutritional components. This isn’t necessarily a red flag, but with any supplements, you simply have to do your research and start slow.

  Also, you might find that the dosage for particular ingredient needs additional supplementation, for example, 2500mg of creatine is lower than the recommended dose from many health experts. For me, I’ve had to supplement with additional creatine and collagen, so it is not a 1-scoop solution by itself.

To wrap it up - I’m a fan.

I’m continuing to take it, and while it doesn’t take the place of my entire diet/supplement needs, it checks a lot of boxes and its convenient for me in my busy day.

👉🏾 Learn more about Blueprint’s “Longevity Mix”

— Ethan, Editor-in-Chief

P.S. DO YOUR OWN RESEARCH. READ REVIEWS. START SLOW.

FROM THE CLINIC

LOYAL’S LONGEVITY TRIAL FOR CANINES HITS 1,000 PARTICIPANTS

Loyal, a San Francisco-based biotech company, has reached a significant milestone by enrolling 1,000 dogs in its STAY study, the largest clinical trial in veterinary history.

This trial evaluates LOY-002, a daily beef-flavored pill aimed at extending the healthy lifespan of senior dogs by improving metabolic health.

The study, which began in late 2023, includes dogs aged 10 and older, weighing at least 14 pounds, across 70 veterinary clinics nationwide .

The FDA has acknowledged a "reasonable expectation of effectiveness" for LOY-002, paving the way for potential conditional approval by late 2025 . Loyal plans to expand enrollment to 1,300 dogs, further advancing its mission to enhance canine longevity.​

👉🏾 Read the full story on the latest milestone for Loyal.